Skin-Related Medical Encounters Across 396 Multiday Ultramarathon Runners
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: What did this specific study measure, in whom, at what timepoint—and what would go beyond its evidence?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 396 runners competing in seven-day, 250-km RacingThePlanet Four Deserts ultramarathons during 2005–2006. |
| Design | Prospective event surveillance of all medical encounters with descriptive analysis and multivariable modeling. |
| Comparator | Encounter patterns were compared across race days and participant age, sex and completion time. |
| Timepoint | Seven days of racing. |
| Key result | Eighty-five percent of runners required medical care across 1,173 encounters. The overall rate was 3.86 encounters per runner and 65 per 1,000 running-hours; 74.3% were skin-related. Skin and musculoskeletal problems peaked on days three or four. A ten-year age increase was associated with 0.5 fewer total injuries or illnesses. |
| Funding/conflict context | The PubMed abstract does not state funding or conflict disclosures. No moisturizer was evaluated. |
What was actually measured?
Eighty-five percent of runners required medical care across 1,173 encounters. The overall rate was 3.86 encounters per runner and 65 per 1,000 running-hours; 74.3% were skin-related. Skin and musculoskeletal problems peaked on days three or four. A ten-year age increase was associated with 0.5 fewer total injuries or illnesses.
Prospective event capture describes when care was needed, but encounters are not unique people and event medical thresholds may differ across races.
The denominator defines the scope. A workplace outbreak, clinic series, questionnaire, case report and long-term cohort answer different questions. Their percentages and odds ratios cannot be silently transferred to another population.
What the result does not prove
Specific extreme events, encounter-based denominator, mostly minor conditions, historical field conditions and no non-racing comparison limit generalization.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors’ conclusions, this interpretation or any product.
Exposure detail matters more than the job label
People with the same title may handle different materials for different durations. Useful documentation identifies the exact product or process, route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, chemical, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve away from work or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredients and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 21552155
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Chemical-Related Symptoms in 183 Hospital and Campus Cleaners
- Thirteen-Year Hand-Eczema Outcomes in 1,494 Car-Industry Workers
- Saddle-Sore Burden in 33 Elite and Professional Cyclists
- 474 Time-Loss Skin Infections Across 20.9 Million High-School Athlete Exposures
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.